Amgen is probed by Danish regulator after employee posts press release on LinkedIn
nyone who likes to post information about drugs on social media might want to read this: The Danish Medicines Agency is investigating whether an Amgen (AMGN) employee in Denmark violated advertising laws by sharing and liking a U.S. press release about the Kyprolis medication on LinkedIn. If the law was broken, the company may have to pay a penalty and the employee could face up to four months in jail.
An agency spokesman declined to provide further details, but explained that advertising prescription medicines to the general public is prohibited. Under Danish law, the general public is defined as anyone who is not a doctor, dentist, veterinarian, pharmacist, nurse, midwife, bioanalyst, clinical dietitian, radiographer, or student in one of these fields.